Despite US warning, India-Russia keen on S-400 missile deal and hi tech weapon manufacturing

Despite United States warning, India is keen on manufacturing high-tech weapons with Russia under PM Modi’s Make-in-India initiative, Russian Foreign Minister Sergei Lavrov in a meeting with his counterpart S Jaishankar stated on Tuesday.

The top ministers from the two countries had a conversation on a wide range of issues associated with Afghanistan, space, defense, partnership in nuclear, manufacturing, economic, and vaccine cooperation. They also conceded building a free trade zone between India and the Eurasian Economic Union to strengthen bilateral relations.

Sergey Lavrov stated in a joint press conference that both sides talked about military cooperation, including the manufacturing of Russian weapons in India under the “Atmanirbhar Bharat” and “Make in India” initiatives. In this strategically significant area, Russia is a primary international contractor for India. Lavrov added that both nations have also conceded to join hands in tackling a decline in mutual trade because of the pandemic. 

A coordinated effort on the coronavirus vaccines was also discussed, and Lavrov notified that the Russian Direct Investment Fund (RDIF) has marked agreements with a few Indian companies to make around 750 million doses of the Sputnik V immunization. 

He didn’t rule out further collaboration to cover the making of Indian vaccines in Russia, while Jaishankar stated that the regulatory authorities of both nations will be deciding on the matter. As far as we might be concerned, if those vaccines to be manufactured in India, it would be one more assertion of the significance of ‘Make in India’ and on our own vaccine capabilities,” Jaishankar added.

Related Posts

In January, the United States had cautioned India it is probably not going to get a waiver on its outlined procurement of Russian S-400 missiles, increasing the risk of sanctions like those forced on Turkey for purchasing the same, officials aware of the issue told India Today News

Moreover, the Trump administration has been advising India to drop the $5.5 billion agreement for five missiles and circumvent a geopolitical crisis, stating that New Delhi didn’t have a wide waiver from a 2017 US law pointed toward preventing nations from purchasing Russian military equipment. 

However, India states that it requires long-range surface-to-air missiles to be equipped to counter the increasing threat from China. India and China relations are at their lowest point lately due to the contention on the Himalayan border since last April.

Geopolitical Monitor

The daily developments on front of geopolitical relations and agendas are guaranteed to be brought to you. Assuring to bring to you the most unique point of view regarding the global developments

Recent Posts

Austria’s Infrastructure Ambition: How Austria’s Infrastructure Investment Is Redefining Europe’s Future

Austria is becoming an exception story in Europe that is succeeding by investing in long-term investment in infrastructure. Austria infrastructure… Read More

December 13, 2025

Sudan’s Crisis in Focus: What BBC Investigations and Al-Hurra Reports Reveal

The crisis in Sudan has quickly turned into one of the most threatening crises in the area that involves humanitarian… Read More

December 13, 2025

Key Middle East Rail Project Updates You Should Know

This article on modern mobility, sustainable transport and across-border connectivity describes how the Key Middle East rail project is being… Read More

December 12, 2025

Planning To Travel To Europe In 2026? Here Are 7 Key Updates You Need To Be Aware Of

Planning a trip to Europe in 2026? The continent will present some of the biggest changes that will impact global… Read More

December 12, 2025

UAE Pledges $550 Million to Boost UN’s 2026 Global Humanitarian Response

The United Arab Emirates is a country that has announced a significant humanitarian initiative by promising USD 550 million to… Read More

December 11, 2025

Europe’s Path to a Unified Clinical Trials Ecosystem

Europe is also striving to create a single clinical trials ecosystem so it can enhance its standing in international medical… Read More

December 11, 2025

This website uses cookies.

Read More